4DX.ASX: 3-year contract extension secured with the Cleveland Clinic

3-year contract extension secured with the Cleveland Clinic

Stock	4DMEDICAL Ltd (4DX.ASX)
Release Time	11 Mar 2025, 8:24 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

4DMedical secures 3-year contract extension with Cleveland Clinic

Key Points

3-year contract extension secured with the Cleveland Clinic
Minimum contract value of A$227,000 over 3 years
Continues trend of growing revenue per site for 4DMedical

Full Summary

Respiratory imaging technology company 4DMedical Limited (ASX:4DX) has announced the renewal and extension of its contract for pulmonary function Software-as-a-Service analysis with the Cleveland Clinic, a world-renowned academic medical centre and research institution. The renewed agreement extends over a 3-year term, with a minimum contract value of A$227,000, and layers on top of an existing multi-year agreement for 4DMedical's pulmonary structure products. The Cleveland Clinic is a globally recognised leader in cutting-edge research and excellence in clinical practice, consistently ranking in the top 3 hospitals in the U.S. and top 10 for pulmonology. This 3-year commercial contract is a significant achievement for 4DMedical, continuing the company's recent growth in revenue per site. 4DMedical's SaaS platform provides advanced imaging analysis, delivering unparalleled insights into respiratory function, and this extension ensures the Cleveland Clinic can continue leveraging 4DMedical's innovative technology to advance respiratory health.

Outlook

4DMedical has numerous opportunities to expand its existing presence at the Cleveland Clinic, with considerable interest shown at recent congresses in the company's current and future portfolio, including CT:VQ™.